Bulletin of Experimental Treatments for AIDS, No. 26; September 1995
Harvey Bartnof, MD
C.C. Wilson, MD, and co-workers reported their findings in the July 1995 issue of Journal of Infectious Diseases. The researchers were able to increase the CD4 count ex vivo by a factor of 1,000 to 10 million. The key to the researchers' success was adding 3 anti-HIV drugs to the tissue cultures, as well as monoclonal antibodies to CD3 and CD8 receptors. The cultures had very low levels of HIV p24 antigen and DNA levels.
According to the authors, the next step in their research would be a clinical trial to determine the possible benefits of infusing the expanded CD4 cells back into participants.
Wilson CC and others. Ex vivo expansion of CD4 lymphocytes from human immunodeficiency virus type-1 infected persons in the presence of combination antiretroviral agents. Journal of Infectious Diseases 172(1): 88-96. July 1995.
950901
BETA2635
Copyright © 1995 - Bulletin of Experimental Treatments for AIDS (BETA). Reproduced with permission. BETA is published four times a year by the San Francisco AIDS Foundation. All rights reserved. Noncommercial reproduction is encouraged. Subscription lists are kept confidential. Call 415.487.8060; FAX: 415.487.8069. Mailing Address: P.O. Box 426182, San Francisco, CA 94142-6182. beta@sfaf.org http://www.sfaf.org/beta.html